株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

単一細胞ゲノミクス・プロテオミクスの世界市場:~2023年

Global Single Cell Genomics and Proteomics Market, Forecast to 2023

発行 Frost & Sullivan 商品コード 911378
出版日 ページ情報 英文 71 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
単一細胞ゲノミクス・プロテオミクスの世界市場:~2023年 Global Single Cell Genomics and Proteomics Market, Forecast to 2023
出版日: 2019年09月03日 ページ情報: 英文 71 Pages
概要

当レポートでは、世界の単一細胞ゲノミクス・プロテオミクスの市場を調査し、主要動向・市場成長への各種影響因子の分析、主要技術とワークフロー、用途・技術・ワークフロー別の収益予測、アンメットニーズと課題、単一細胞技術の展望、将来の用途、注目の企業・技術、成長機会・成功戦略の分析などをまとめています。

エグゼクティブサマリー

市場成長推進因子・抑制因子

競合環境

  • 既存企業:アナリストによる見解
  • 主要技術とワークフロー:競合環境
  • 単一細胞解析のワークフローと技術

資金調達動向

  • 資金調達動向:単一細胞解析スタートアップ企業
  • 資金調達動向:米国リサーチセンター
  • 米国リサーチセンター:前年比分析
  • 商業資金
  • SCGの中心
  • 主な提携

成長機会・推奨行動

  • ハイスループットプラットフォームへのシフト
  • 計算ツールへの焦点の拡大
  • SCGの新たな用途の出現
  • 成功・成長のための戦略的必須要件
  • Mission Bio:DNA単離プラットフォームで先発者の優位性を確保
  • ハイスループット単一細胞解析市場で唯一有名なプラットフォーム
  • Fluidigm:単一細胞解析の産業標準と認識されるものの競合の出現により位置付けを弱める
  • 1CellBio:機械学習による単一細胞の遺伝子発現パターンの特定を目指す、など

収益予測

  • 収益予測
  • 収益予測:用途別
  • 収益の内訳:技術・ワークフロー別

アンメットニーズ・将来の導入エリア

  • 単一細胞解析ワークフローの課題
  • 課題
  • 将来の用途・利用事例

将来の展望

  • 総論・将来の展望
  • 免責事項

付録

FROST & SULLIVANについて

目次
Product Code: 9AB9/B9

Clinical Applications for Single Cell Analysis Remain a Heavily Uncontested Market Place

Single cell genomic and proteomics tools have gained significant importance in the past 2 years. The year 2018 was particularly very active with a lot of platforms made available by both established life sciences tools companies and start-ups. 10X Genomics and Fluidigm have demonstrated the potential for high-throughput single cell applications. There is a constant quest for delivering the lowest cost per cell which is keeping the innovation curve high. Single cell technology developers continue to attract funds from venture capitalists, making it one of the attractive areas to invest in the life science industry. While advancements in the hardware side are addressing throughput and low cost per cell, complexity in the data analysis remains unaddressed, which leaves opportunities to develop analytical tools and bioinformatics pipeline for single cell analysis data. From an application standpoint, while most of the current applications for single cell analysis are restricted to translational research, biopharma applications present the second largest opportunity. Single cell analysis for clinical applications is a long-term opportunity and the company that focuses more on addressing this application will clearly gain the first-mover advantage.

This study analysis the global single cell genomic and proteomic technologies and workflows and identifies key application areas and concepts that can help companies steer their way toward running a successful business. Documented insights from single cell biologists and researchers have been studied to identify current and future applications across translational, biopharma, clinical, and basic research. The study covers an assessment of the market across workflows, technologies, geographic regions and applications. These assessments have been developed after carefully studying 23 companies that are currently offering and developing solutions for single cell isolation and analytical purposes.

Key Issues Addressed:

  • What is the future outlook for single cell technologies?
  • What specific applications offer growth opportunities that can be leveraged by existing and future participants?
  • What are the unmet needs and challenges in the single cell genomics and proteomics industry?
  • What types of technologies (e.g., droplet based) are poised for growth?
  • Who are the major companies offering high-, moderate-, and low-throughput solutions?
  • What applications are driving the update of single cell genomic technologies?
  • What are the strengths of companies offering single cell genomic and proteomic technologies?
  • How will the structure of the market change over time? Is it ripe for acquisitions?
  • How has the industry M&A evolved between various companies offering single cell genomics solutions?
  • Where are the major themes of partnership?
  • Who are the right customers/target audience for platforms?
  • What do they want? What are they willing to pay?
  • Did you mean to say ‘uptake' here? Please check.

Table of Contents

Executive Summary

  • Key Findings
  • Key Findings (continued)
  • Scope and Segmentation
  • Key Questions this Study will Answer

Drivers & Restraints

  • Market Drivers
  • Market Restraints
  • Market Drivers and Restraints (continued)
  • Interest in Single Cell Genomics
  • Research Areas of Interest in Single Cell Analysis
  • Comparison of Traditional Cell Isolation Techniques

Competitive Landscape

  • Analyst's Take on Established Companies
  • Analyst's Take on Established Companies (continued)
  • Analyst's Take on Established Companies (continued)
  • Key Technologies and Workflow-Competitor Landscape
  • Single Cell Analysis Workflow Technology
  • Single Cell Analysis Workflow Technology (continued)
  • Single Cell Analysis Workflow Technology (continued)
  • Single Cell Analysis Workflow Technology (continued)

Funding Trends

  • Early-Stage Company Funding Trends for Single Cell Analysis
  • Early-Stage Company Funding Trends for Single Cell Analysis (continued)
  • U.S Research Center Funding Trends
  • U.S Research Center Funding (Y-o-Y) Analysis
  • Commercial Funding
  • SCG Cores Around the World
  • Key Partnerships
  • Key Partnerships (continued)

Growth Opportunities and Companies to Action (C2A)

  • Shift towards High-Throughput Platforms
  • Increased Focus on Computational Tools
  • Emergence of New Applications for SCG
  • Strategic Imperatives for Success and Growth
  • Mission Bio Gains the First-mover Advantage as the Only DNA Isolation Platform
  • The Only Renowned Platform in the Market for High-throughput Single Cell Analysis
  • While Seen as an Industry Standard for Single Cell Analysis, New Competitors can Weaken Fluidigm's Market Position
  • UK-based Company Set Out to Provide Competition to Existing Single Cell Companies
  • When Combined with Veridex CTC Cell Search Deparray, the Company's Solution Proves its Potential in the Clinical Setting
  • Commercially Launched in December 2018, 1CellBio Aims to Tap into Machine Learning to Identify Patterns of Gene Expression in Single Cells

Revenue Forecast

  • Single Cell Genomics and Proteomics Market-Revenue Forecast
  • Single Cell Genomics and Proteomics Market-Revenue Forecast by Application
  • Revenue Breakdown by Technology and Workflow

Unmet Needs and Future Application Areas

  • Challenges with Single Cell Analysis Workflows
  • Challenges
  • Future Applications and Use Cases
  • Future Applications and Use Cases (continued)

Future Outlook

  • Key Conclusions and Future Outlook
  • Legal Disclaimer

Appendix

  • Computational Tools
  • Computational Tools (continued)
  • List of Companies Mentioned in this Report
  • List of Exhibits
  • List of Exhibits (continued)

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition: Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top